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The-trend towards devolution
in clinical chemistry
Amongst the many branches of chemistry, that associated
with health care is unique for several reasons. It is more
personal because it has to be done for the individual alone.
Unlike the industrial chemists in food factories or sewage
works, the clinical chemist works for single members of a
population. Therefore, he has more scope for his efforts in
numerical terms throughout the world than his colleagues in
other branches. Indeed, if full chemical analytical coverage to
currently accepted standards were made available worldwide,
four billion persons would require an army of some 800,000
scientists-together with laboratories and equipment.
The numbers game and the fact that assays are largely
carried out on one type of material in clinical chemistry-
blood and its constituents which are often in extremely
low concentrations- have led to many analytical firsts for
medical scientists. These include laboratory automation,
gas chromatography and radioimmunoassay to mention only
a few. The post-war explosion in work-loads necessitated the
introduction of automation. The cost and size of the
machines which were rapidly developed as a result brought
centralisation of analytical department. The large central
laboratory flourished because it providedadvantages for the
types of quality control schemes which have been developed
over the last fifteen years. Both computerised and non-
computerised data handling and storage systems were more
easily developed for central laboratories and large eentralised
workloads allowed the appointment of specialised staff to
interpret data.
Centralisation, however, has its problems. Unless a
specimen is to be classified as an emergency, it has to enter
the laboratory organisation machine where specimen
transport, data logging, analysis, reporting and report
transport are costly in time and money. There is no doubt
that if some of the assays could be carried out near the
patient, simply, rapidly and accurately, the advantages to
both the patient and the clinician would be considerable. On-
the-spot decisions could be made on wards. In the outpatient
departments patients might be diagnosed and treatment
commenced without the awaiting of results requiring further
visits. The GP would also find many advantages if he were
able to do chemical analyses in his surgery or while on
domiciliary visits.
Scrutiny of the work-loads of the large centralised laborat-
ories shows that only about ten different types of assay
account for 85% of the total performed. This small qualit-
ative but large quantitative part of the work contributes
much to the present tendency towards considering large
laboratories more as factories than as scientific departments.
There is some truth in the claim by technical staff in various
countries that with their increasing management experience
they can run such centres as well as, or better than, those
who profess to be scientists. Centralisation took place
because the trend of technological development led to the
highest efficiency being, produced using large instruments
.with large workloads. It is now apparent that accuracy,
precision and cost effectiveness are not the sole prerogative
of the large machines and centres. Their advantages are
slowly diminishing for several, reasons.
(1) The cost, size and efficiency of solid-state electronics
and data processors allows them to be used in small machines
with dramatic effect.
(2) The use of pre-packaged reagents has shown the value
of the high level quality control which is possible in the
commercial mass production of this material.
(3) Reliance upon a single large machine which is inevit-
ably liable to breakdown has caused problems on many
occasions.
(4) Large machines in the past have been criticised for
their inflexibility.
(5) Time and effort can be expended in organising the
conveyance of specimens to the central laboratory, and the
distribution reports therefrom.
(6) Biochemical profiling, where many assays are carried
out on an individual, regardless of whether or. not they are
indicated by illness, require the development of large
machines, but the extent of the value of such .profiling has
recently been widely questioned.
(7) Funds cannot be readily acquired to cover the cost of
equipping and running large centres for much of the world’s
population, nor are the maintenance arrangements and
suitable electricity supplies available.
(8) Exciting new techniques for example layer chemistry,
hold considerable potential for application to small instru-
ments operated,by relatively inexperienced individuals work-
ing in relative isolation.
The new generation of instruments suitable for devolution
can cover a variety of situation. One answer for the small
independent laboratory has been available for the last
decade. This is the principal of high quality pre-packaged
chemistry, as use.d in the Du Pont ACA, or more recently
in the Technicon STAC. Realisation of the potential that this
approach could have has proceeded extremely slowly. This
undoubtedly accounts for the slow but steadily increasing
sales of an instrument, conceived 10 years ahead of its time.
When such a machine is installed in a ward environment or
similar situation near to the patients it is meant to serve, the
high costs of its reagents are counter-balanced by the
somewhat imponderable savings produced by speedy results
increasing the efficiency of the clinician and the convenience
of his patients, and eliminating the overhead costs of the
large laboratory.
It could be argued that this method of devolution will
make it difficult or impossible to operate an efficient data
processing or data banking, system, the value of which has
become apparent in the overall operation of the centralised
laboratory. Modern computer systems with distant terminals
now make it possible for input and output devices,
connected to a central processor, to operate at almost
any distance. Even if on-line operation is not appropriate,
off-line cassette tape recording can be an effective system of
communication. If a direct link to a central processor is
feasible, the processing power available to a small distant
instrument is almost unlimited and in this way many of the
restrictions enforced on the chemistry operable on such a
small instrument can be overcome.
Several automatic colorimeters are now available for use
where the sophistication and cost of fully automated pack-
aged chemistry instruments are not appropriate. They may
be pre-programmed or programmable for a large range of
assays; their use removes a fair proportion of the chances of
human error which are associated with optical density
reading and the subsequent calculations. For isolated and
developing country situations, this approach is at present
probably the most ideal, but instruments must be simple
to operate, capable of maintenance-free running for many
years and have a power consumption such that they can
function for long periods on an integral battery.
For satisfactory operation, all such automatic colori-
meters must be used in association with equally simple-to-use
trouble-free chemistry. The development of new technol-
ogies, together with a need to serve a larger proportion of the
world’s population, must of necessity produce changes, and
Volume 1 No. 4,July 1979 179Commentary
rational argument would appear to point away from central-
isation; just as sure as the automation of clothes washing
first led to big central laundries with large capacity machines,
and then to their partial demise following the evolution of
the highly efficient home washing machine and community
launderette.
From the Editor’s desk
F.L. Mitchell
This issue marks a significant point in the Journal of
Automatic Chemistry’s life, the final issue of the first forn-
ative year, but Volume will be completed with the October
issue. Whilst there has been a healthy supply of papers being
submitted for consideration in the Journal there has not been
a flood of letters from the readership. Those letters we have
received express the value of the new journal and they
encourage us to continue along the lines established through-
out the first year. In general the breakdown of readership is
approximately divided equally between those with clinical
and those with industrial interests. My own colleagues
with an industrial background find considerable use reading
all the articles so it is worthwhile not being put off by the
title of the paper or by the affiliation of the authors. There
is considerable similarity in approach and problem between
work within an organisation such as the Clinical Research
Centre and work relating to the analysis of tobacco smoke at
the Laboratory of the Goverment Chemist. There is a great
deal to be gained by communications across disciplines it
is too easy to say that there is far too much to read on
one’s own subject area. However, there is a common interest
in instrumentation and it is vital that the advantages of
microprocessors and new technical developments are
integrated correctly into our working lives. This submit,
requires a collective objective.
In his editorial commentary Dr. Mitchell discusses the
shift from centralised power to local control. This is a very
important change, however it does not detract from the
value that can be gained by a centralised facility, but it does
more easily put the control where it ought to be. Any user of
a computer system wants to feel that he is in complete
control. How this is achieved is not important but many of
the centralised approaches in the past have failed to meet this
objective. Successful manufacturers are producing instruments
more in line with the market needs. The control of the
instrument must be situated with the instrument. However, it
is vitally important that such instruments are able to
communicate with each other andwith a central intelligence.
The first attempts by Hewlett Packard to introduce micro-
processor technology into their automated gas chromato-
graphs did not achieve a great degree of acceptance, they
were unable to talk simply to other computers. The second
generation from the same company has not a similar fault, is
expandable and represents a significant advance in the first
attempt. With such advantages there are really two problems
that must be overcome. It is important to standardise inter-
faces so that it is a relatively simple matter of a connection
to other instruments or computers. There is also a need to
generate truly portable software packages. Software is a
subject which is generally glossed over in the literature but it
is a very costly item which must be integrated into the cost
benefit equation. Many instrument manufacturers absolve
themselves from this discussion by offering a basic computer
on the grounds that everybody will be able to ’speak’ basic
in the near future.
The paper by Professor Bonner Denton published in the
third issue of the Journal of Automatic Chemistry attempts
to overcome one part of the problem, that of control. The
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availability of cheap development computers such as the
Commodore PET is also seen by some as a way out of the
problem. However, in my own experience, whilst the
hardware is generally a quantifiable aspect of the problem,
the software in terms of specification and production is both
more expensive and difficult to obtain in acceptable
timescales.
At the 3rd European Congress of Clinical Chemistry at
Brighton, (a report of this appears on page 226 ), I was
able to hold an editorial meeting with my clinical corres-
ponding editors who had assembled for the meeting. This was
of considerable value and many useful suggestions helpful to
the progress of the Journal emerged. One important point
was that the meeting complemented the face to face meeting
I have had with each member of the editorial team. This
will make it much easier in future to correspond between
ourselves, and will am sure increase the flow of infor-
mation. Perhaps the most useful point that emerged is that
Dr. Collombel suggested that a glossary of published
evaluation reports should be published in the Journal on a
continuing basis. A retrospective list of all instrument evalu-
ations currently available will be published and periodically
will be updated. In conjunction with the references a short
abstract of the evaluation will be provided.
Clinical chemists place considerable value on evaluation
reports, and have established a protocol for such evaluations.
In industrial applications such reports are not in vogue. They
are often confined to intra-organisational reports and not
published in the scientific literature. However, with consider-
able pressure on available resources it is hoped that some
standardisation of evaluation report in the industrial market
can emerge. Certainly it seems that this is one area where
industrial chemists can learn from our clinical colleagues.
One useful role of the Journal is to publish evaluation reports
and to do this in a quick timescale. It is an important factor
in the communication of information from manufacturers to
users and vice versa.
Peter B. Stockwell
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